Therapy Areas: Central Nervous System
21 September 2020 - - The first patient has been enrolled in the "CURE" study, Germany-based biotechnology company Algiax Pharmaceuticals, a clinical-stage biotechnology company focused on d...
14 September 2020 - China-based Luye Pharma Group has signed two contracts with partners in Latin America to help develop the central nervous system drugs Seroquel and Seroquel XR in local markets, it...
8 September 2020 - - The US Food and Drug Administration has approved Gavreto (pralsetinib) for the treatment of adults with metastatic rearranged during transfection fusion-positive non-small cell lu...
7 September 2020 - Blueprint Medicines Corporation (NASDAQ: BPMC), a US-based precision therapy company, has received approval from the US Food and Drug Administration (FDA) for its GAVRETO (pralsetin...
4 September 2020 - - US-based contract research organisation PPD, Inc. (NASDAQ: PPD) and Lupus Therapeutics, an affiliate of the Lupus Research Alliance known for its lupus clinical trials e...
2 September 2020 - - US-based biopharmaceutical company Omeros Corp's (NASDAQ: OMER) Investigational New Drug Application to begin clinical trials with OMS906 has been cleared by the US Food and ...
Related Headlines